News
Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.
14m
Money Talks News on MSN5.3 Million Medicare Users to Benefit From New Drug Price NegotiationsThe next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...
Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...
Novo Nordisk shares dropped as low as $46.90 in Thursday’s session, their lowest level since January 2022, following a profit warning.
Global pharmaceutical stocks dropped after President Trump wrote to 17 companies asking them to [cut the costs of drugs]( ...
Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable drugs that have grown popular in recent years for their abilities to ...
The Trump administration outlines a plan to cover weight-loss drugs under Medicare and Medicaid, allowing certain state ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
Employers are bracing for higher health insurance premiums in 2026, with some reports of double digit percentage hikes.
When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...
Kumar now believes the stock is only worthy of a hold recommendation, down from his previous assessment of buy. He also significantly lowered his price target, chopping it to 360 Danish krone ($55.49) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results